Clinical Trial Update: Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating goal-directed hemodynamic therapy guided by ECOM to reduce morbidity and mortality after cardiac surgery; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University Hospital, Caen | Conditions: Coronary Surgery With Cardiopulmonary Bypass | Phase 4 | Status: COMPLETED